Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
24 Jan 2017 | 8:57 PM
 

Nectar Lifesciences Ltd. Share Price Live (BSE)
0

BSE Code: 532649 | NSE Symbol: NECLIFE
34.40
0.05
(0.15 %)
24 Jan 2017 | 04:01 PM
Change company
  • Open (Rs)
    34.60
  • Prev. close (Rs.)
    34.35
  • High (Rs.)
    34.60
  • Low (Rs.)
    34.21
  • 52W H (Rs.)
    47.85
  • 52W L (Rs.)
    28.55
  • Volume (Rs.)
    21500
  • MCap (Rs in Cr.)
    613.22
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
2.64
Operating Margin (%)
16.38
Gross Profit Margin (%)
11.29
Net Profit Margin (%)
3.53
Total Debt/Equity
0.86
Dividend payout Ratio (Net Profit)
4.56
Earning Retention Ratio
95.44

News

23 Aug 2016 - 17:28:00-Pharma major Nectar Lifesciences Ltd on Tuesday reported a drop of 16...
29 Dec 2015 - 13:07:00-Pharma major Nectar Lifesciences Ltd on Tuesday said it’s Board of Directors has appointed Gul...
17 Dec 2015 - 09:54:00-Leading pharma company Nectar Lifesciences has said that it has been honored with the coveted Nation...
15 May 2015 - 13:13:00-Pharma major Nectar Lifesciences Ltd on Friday said it has received ANVISA cGMP (Current Good Manufa...

Announcements

06-Jan-2017
Nectar Lifesciences - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Dec
05-Jan-2017
Nectar Lifesciences - Shareholding for the Period Ended December 31 2016
14-Dec-2016
Nectar Lifesciences - Standalone Financial Results Limited Review Report for September 30 2016
06-Dec-2016
Nectar Lifesciences - Board Meeting Intimation for Results & Closure of Trading Window
07-Oct-2016
Nectar Lifesciences - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Sep

Religare Research

24 Jan 2017 | 12:04 PM
2017-18 Pre Budget Expectations for Currency Markets
24 Jan 2017 | 09:47 AM
The Indian rupee was little changed against the dollar, as demand for the greenback from importers w...
24 Jan 2017 | 09:39 AM
Agri Fundamental report
24 Jan 2017 | 09:39 AM
Agri Technical report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors55.80%
Mutual Funds/UTI0.00%
FI/Banks0.91%
Insurance0.91%
FII3.37%
Government0.00%
Others23.19%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,025.00(-1.28)
11816
 Neuland Laboratories Ltd.
975.00(0.29)
3578
 AstraZeneca Pharma India Ltd.
960.25(0.07)
3274
 Merck Ltd.
945.05(0.66)
3302

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Nectar Lifesciences Ltd.1.15-1.50-2.90
NIFTY(S&P CNX)490.05-233.15-159.85
BSE SENSEX1,334.88-803.50-719.76
BSE 500783.28-388.0925.82

Corporate Details

Key Personal
Dinesh Dua
Director & CEO
Harprakash Singh Gill
President & Director
Rima Marphatia
Nominee Director
Key Address
Registered Office
Village Saidpura Tehsil Derabassi Distt. S.A.S. Nagar,Mohali,Punjab

Tel:01762-308000 308001, Fax:01762-281187 308135

sunderlal@neclife.com
http://www.neclife.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Nectar Lifesciences Ltd. that will help you decide whether to buy, sell or hold Nectar Lifesciences Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Nectar Lifesciences Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.